Interleukin 5 and 13 characterize immune response to respiratory sensitizing acid anhydrides

Journal of Applied Toxicology

Volumn 22, Issue 5, 2002, Pages 317-325

  Dearman, Rebecca J ^a   Filby, Andrew ^a   Humphreys, Ian R ^a   Kimber, Ian ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Chemical allergens; Interleukin 13; Interleukin 5; Tc subsets; Th subset

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACID ANHYDRIDE; ALLERGEN; INTERLEUKIN 13; INTERLEUKIN 5; MALEIC ANHYDRIDE; MITOGENIC AGENT; PHTHALIC ANHYDRIDE; TRIMELLITIC ANHYDRIDE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; FEMALE; IMMUNOLOGY; LYMPH NODE; METABOLISM; MOUSE; SECRETION; TH2 CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DATA ANALYSIS; EXPOSURE; IMMUNE RESPONSE; LYMPH NODE CELL; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; RESPIRATORY TRACT ALLERGY; SENSITIZATION;

ALLERGENS; ANHYDRIDES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DINITROCHLOROBENZENE; FEMALE; INTERLEUKIN-13; INTERLEUKIN-5; LYMPH NODES; MALEIC ANHYDRIDES; MICE; MICE, INBRED BALB C; MITOGENS; PHTHALIC ANHYDRIDES; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS;

EID: 0036708569     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.865     Document Type: Article

References (47)

1. Sallie BA, Ross DJ, McDonald JC. SWORD '93: surveillance of work-related and occupational disease in the UK. Occup. Med. 1994; 44: 177-182.
2. Ross DJ, Sallie BA, McDonald JC. SWORD '94: surveillance of work-related and occupational disease in the UK. Occup. Med. 1995; 45: 175-178.
3. Chan-Yeung M, Malo J-L. Compendium 1. Table of major inducers of occupational asthma. In Asthma in the Workplace, Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI. (eds). Marcel Dekker: New York, 1993; 595-623.
4. Cullinan P. Occupational asthma, IgE and IgG. Clin. Exp. Allergy 1998; 28: 668-670.
5. Mapp C, Boschetto P, Miotto D, De Rosa E, Fabbri LM. Mechanisms of occupational asthma. Ann. Allergy Asthma Immunol. 1999; 83: 645-664.
6. Keskinen H, Tupasela O, Tiikkainen U, Nordman H. Experiences of specific IgE in asthma due to isocyanates. Clin. Allergy 1988; 18: 597-604.
7. Wass U, Belin L. Immunological specificity of isocyanate-induced IgE antibodies in serum from 10 sensitized workers. J. Allergy Clin. Immunol. 1989; 83: 126-135.
8. Tee RD, Cullinan P, Welch J, Burge PS, Newman Taylor AJ. Specific IgE antibody to isocyanates: a useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 1998; 101: 709-715.
9. Zeiss CR, Patterson R, Pruzansky JJ, Miller MM, Rosenberg M, Levitz D. Trimellitic anhydride-induced airway symptoms: clinical and immunologic studies. J. Allergy Clin. Immunol. 1977; 60: 96-103.
10. Topping MID, Venables KM, Luczynska CM, Howe W, Newman Taylor AJ. Specificity of the human IgE response to inhaled acid anhydrides. J. Allergy Clin. Immunol. 1986; 77: 834-842.
11. Taylor AJ, Venables KM, Durham SR, Graneek BJ, Topping MD. Acid anhydrides and asthma. Int. Arch. Allergy Appl. Immunol. 1987; 82: 435-439.
12. Yokota K, Johyama Y, Yamaguchi K, Fujiki Y, Takeshita T, Morimoto K. Specific antibodies against methyltetrahydrophthalic anhydride and risk factors for sensitization in occupationally exposed subjects. Scand. J. Work Environ. Health 1997; 23: 214-220.
13. Baur X, Czuppon A. Diagnostic validation of specific IgE antibody concentrations, skin prick testing, and challenge tests in chemical workers with symptoms of sensitivity to different anhydrides. J. Allergy Clin. Immunol. 1995; 96: 489-494.
14. Maccia CA, Bernstein IL, Emmett EA, Brooks SM. In vitro demonstration of specific IgE in phthalic anhydride hypersensitivity. Am. Rev. Respir. Dis. 1976; 113: 701-704.
15. Neilsen J, Welinder H, Schutz A, Skerfving S. Specific serum antibodies against phthalic anhydride in occupationally exposed subjects. J. Allergy Clin. Immunol. 1988; 82: 126-133.
16. Kimber I, Dearman RJ. Cell and molecular biology of chemical allergy. Clin. Rev. Allergy Immunol. 1977; 15: 145-168.
17. Dearman RJ, Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J. Appl. Toxicol. 2001; 21: 153-163.
18. Dearman RJ, Warbrick EV, Humphreys IR, Kimber I. Characterization in mice of the immunological properties of five allergenic acid anhydrides. J. Appl. Toxicol. 2000; 20: 221-230.
19. Azuma M, Hirano T, Miyajima H, Watanabe N, Yagita H, Enomoto S, Furusawa S, Ovary Z, Kinashi T, Honja T. Regulation of IgE production in SJA/9 and nude mice. Potentiation of IgE production by recombinant interleukin 4. J. Immunol. 1987; 139: 2538-2544.
20. Finkelman FD, Katona IM, Urban Jr JF, Holmes J, Ohara J, Tung AS, Sample JG, Paul WE. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 1988; 141: 2335-2341.
21. Smith CA, Rennick DM. Characterization of a murine lymphokine distinct from interleukin 3 (IL-3) possessing T cell growth factor activity and a mast cell growth factor activity that synergizes with IL-3. Proc. Natl. Acad. Sci. USA 1986; 83: 1857-1861.
22. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. Interleukin-10: a novel stimulatory factorfor mast cells and their progenitors. J. Exp. Med. 1991; 173: 507-510.
23. Yokota T, Coffman RL, Hagiwara H, Rennick DM, Takebe Y, Yokota K, Gemmell L, Schrader B, Yang G, Meyerson P. Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing and eosinophil-colony stimulating factor activities. Relationship to IL-5. Proc. Natl. Acad. Sci. USA 1987; 84: 7388-7392.
24. Iwamoto I, Takatsu K. Evaluation of airway hyperreactivity in interleukin-5 transgenic mice. Int. Arch. Allergy Immunol. 1995; 108: 28-30.
25. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J. Exp. Med. 1996; 183:195-201.
26. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TL, Karp CL, Donaldson DD. Interleukin 13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
27. Grunig G, Warnock M, Wakil AD, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2262.
28. Dearman RJ, Kimber I. Differential stimulation of immune function by respiratory and contact chemical allergens. Immunology 1991; 60: 563-570.
29. Dearman RJ, Basketter DA, Kimber I. Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens. Immunology 1995; 86: 545-550.
30. + T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 1996; 89: 502-510.
31. + T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo. Int Arch. Allergy Immunol. 1998; 116:116-123.
32. + T helper 2 (Th2) type cells in cutaneous responses induced by fluorescein isothiocyanate. Immunology 2000; 101: 442-451.
33. + T cells: their activation and effector functions. Curr. Opin. Immunol. 1994; 6: 453-457.
34. + T cells secreting Thl or Th2 cytokines. Immunity l995; 2: 271-279.
35. + T cells. J. Allergy Clin. Immunol. 1997; 100: 781-792.
36. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 1997; 158: 3539-3544.
37. + T cells in atopic disease. Curr. Opin. Immunol. 1998; 10: 628-633.
38. Till S, Dickason R, Huston D, Humbert M, Robinson D, Larche M, Robinson DS, Durham SR, Kay AB. IL-5 secretion by allergen-stimulated CD4' T cells in primary culture: relationship to expression of allergic disease. J. Allergy Clin. Immunol. 1997; 99: 563-569.
39. Bancroft AJ, McKenzie ANJ, Grencis R. A critical role for IL-13 in resistanceto intestinal nematode infection. J. Immunol. 1998; 160: 3453-3461.
40. Betts CJ, Dearman RJ, Flanagan BF, Kimber I. Temporal changes in cytokine gene expression profiles induced in mice by trimellitic anhydride. Toxicol. Lett. in press.
41. Zurawski SM, Vega Jr F, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993; 12: 2663-2670.
42. Wills-Karp M. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 2001; 107: 9-18.
43. Fallon PG, Emson CL, Smith P, McKenzie ANJ. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J. Immunol. 2001; 166:.2712-2717.
44. Webb DC, McKenzie ANJ, Koskinen AML, Yang M, Mattes J, Foster PS. Integrated signals between IL-4, IL-5 and IL-13 regulate airways hyperreactivity. J. Immunol. 2000; 165: 108-113.
45. Corry DB. IL-13 in allergy: home at last. Curr. Opin. Immunol. 1999; 11: 610-614.
46. Kitagaki H, Ono N, Hayakawa K, Kitizawa T, Watanabe K, Sihohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper 1 to a T helper 2 profile. J. Immunol. 1997; 159: 2484-2491.
47. Yokota K, Yamaguchi K, Takeshita T, Morimoto K. The association between serum levels of Th cytokines and rhinoconjunctivitis caused by methyltetrahydrophthalic anhydride. Allergy 1998; 53: 803-807.